Subtype
Liver Neoplasm
CI-CAN-00001077Explore in graph →
Non-malignant930 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001077Explore in graph →
Clinical trials
4,334 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03124498 | A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA | unknown | Phase 1 / Phase 2 | 55 | Chuan An Biotechnology Co., Ltd.INDUSTRY | 0 | Apr 21, 2017 | clinicaltrials |
| NCT03110068 | Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma | unknown | — | 370 | Ming KuangOTHER | 0 | Apr 12, 2017 | clinicaltrials |
| NCT00730860 | Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE | unknown | N/A | 140 | Southwest Hospital, ChinaOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT03084380 | Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 20 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 20, 2017 | clinicaltrials |
| NCT03082378 | Central Obesity and Hepatocellular Carcinoma | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT01869088 | TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma | unknown | Phase 3 | 266 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT02729493 | Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer(EECLC) | unknown | N/A | 25 | Sinobioway Cell Therapy Co., Ltd.INDUSTRY | 1 | Mar 15, 2017 | clinicaltrials |
| NCT03069508 | Clemizole HCl for Subjects With Hepatocellular Carcinoma | unknown | Phase 2 | 12 | Eiger Group International, Inc.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03066557 | Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma | unknown | N/A | 80 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Feb 28, 2017 | clinicaltrials |
| NCT02936856 | Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications(RDSA) | unknown | N/A | 200 | Guangxi Medical UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02956772 | Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 2 | 190 | Hunan Provincial People's HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02783261 | Prospective Post Y90 Liver Hypertrophy | unknown | — | 25 | Singapore General HospitalOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03046979 | Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)(HCC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03020342 | HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC | unknown | — | 50 | National Taiwan University HospitalOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT01966133 | TACE as an Adjuvant Therapy After Hepatectomy for HCC | unknown | Phase 3 | 280 | Jia FanOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT03010085 | Open Versus Laparoscopic Left-sided Hepatectomy Trial(OLLEH) | unknown | Phase 3 | 122 | Ewha Womans University Mokdong HospitalOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Dec 28, 2016 | clinicaltrials |
| NCT02742727 | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02969096 | Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma | unknown | Phase 2 | 30 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | Nov 21, 2016 | clinicaltrials |
| NCT02959151 | A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy | unknown | Phase 1 / Phase 2 | 20 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02738697 | Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection | unknown | Phase 3 | 290 | Sun Yat-sen UniversityOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00606385 | Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC(HCC) | unknown | N/A | 84 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02813096 | Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients | unknown | N/A | 500 | Guangxi Medical UniversityOTHER | 0 | Oct 25, 2016 | clinicaltrials |
| NCT02523053 | Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients | unknown | N/A | 160 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT02630108 | TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma | unknown | Phase 3 | 280 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02363218 | Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife | unknown | Phase 2 | 117 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02873442 | Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02809534 | A Study of Anlotinib in Patients With Hepatocellular Carcinoma(ALTER0802) | unknown | Phase 2 | 60 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 7, 2016 | clinicaltrials |
| NCT02862613 | Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer | unknown | Phase 1 / Phase 2 | 40 | Shanghai International Medical CenterINDUSTRY | 1 | Sep 2, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02882659 | Dendritic Killer Cell-based Immunotherapy for Solid Tumors | unknown | Phase 1 | 18 | FullHope Biomedical Co., Ltd.INDUSTRY | 0 | Aug 30, 2016 | clinicaltrials |
| NCT02847767 | Dynamic Contrast Enhanced HCC SABR Liver Study | unknown | N/A | 20 | British Columbia Cancer AgencyOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02399735 | Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation | unknown | Phase 1 | 18 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT02436564 | In Vitro Models of Liver and Pancreatic Cancer | unknown | — | 75 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02827786 | Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours | unknown | N/A | 30 | Enhanced MedicalINDUSTRY | 1 | Jul 11, 2016 | clinicaltrials |
| NCT02811666 | Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers(A15-10) | unknown | N/A | 200 | CHU de ReimsOTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT02487017 | DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02772029 | A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure | unknown | Phase 1 / Phase 2 | 30 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 0 | May 13, 2016 | clinicaltrials |
| NCT02563158 | Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC(OHx-NOHx) | unknown | N/A | 114 | Chinese PLA General HospitalOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT02758977 | Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)(ALPPSforCRLM) | unknown | N/A | 214 | University of ZurichOTHER | 1 | May 3, 2016 | clinicaltrials |
| NCT02757846 | Radiomics of Hepatocellular Carcinoma | unknown | — | 1,200 | Chinese Academy of SciencesOTHER_GOV | 1 | May 2, 2016 | clinicaltrials |
| NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | unknown | Phase 3 | 198 | Sun Yat-sen UniversityOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02745600 | Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment(ClinicIMPPACT) | unknown | N/A | 60 | University of LeipzigOTHER | 4 | Apr 22, 2016 | clinicaltrials |
| NCT02301091 | Combine TACE and RFA Versus TACE Alone for HCC With PVTT(CORTT) | unknown | Phase 3 | 240 | Ming ZhaoOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02423239 | A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | unknown | Phase 1 | 112 | e-Therapeutics PLCINDUSTRY | 4 | Apr 6, 2016 | clinicaltrials |
| NCT02729506 | Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | unknown | Phase 4 | 150 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02727309 | A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients | unknown | Phase 1 / Phase 2 | 30 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 4, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Apr 21, 2017source: clinicaltrials